Cargando…

Translation of immunomodulatory therapy to treat chronic heart failure: Preclinical studies to first in human

BACKGROUND: Inflammation has been associated with progression and complications of chronic heart failure (HF) but no effective therapy has yet been identified to treat this dysregulated immunologic state. The selective cytopheretic device (SCD) provides extracorporeal autologous cell processing to l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Humes, H. David, Aaronson, Keith D., Buffington, Deborah A., Sabbah, Hani N., Westover, Angela J., Yessayan, Lenar T., Szamosfalvi, Balazs, Pagani, Francis D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079025/ https://www.ncbi.nlm.nih.gov/pubmed/37023139 http://dx.doi.org/10.1371/journal.pone.0273138

Ejemplares similares

Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients
por: Yessayan, Lenar T., et al.
Publicado: (2022)

Innovations in CKRT: individualized therapy with fewer complications
por: Szamosfalvi, Balazs, et al.
Publicado: (2020)

Regenerative Medicine and Immunomodulatory Therapy: Insights From the Kidney, Heart, Brain, and Lung
por: Pino, Christopher J., et al.
Publicado: (2018)

An Immunomodulatory Device Improves Insulin Resistance in Obese Porcine Model of Metabolic Syndrome
por: Westover, Angela J., et al.
Publicado: (2016)

Use of extracorporeal immunomodulation in a toddler with hemophagocytic lymphohistiocytosis and multisystem organ failure
por: Goldstein, Stuart L., et al.
Publicado: (2022)

Regional citrate anticoagulation “non-shock” protocol with pre-calculated flow settings for patients with at least 6 L/hour liver citrate clearance
por: Yessayan, Lenar, et al.
Publicado: (2021)

Targeting the Mitochondria in Heart Failure: A Translational Perspective
por: Sabbah, Hani N.
Publicado: (2020)

Safety Summary of the Selective Cytopheretic Device: A Review of Safety Data Across Multiple Clinical Trials in ICU Patients With Acute Kidney Injury and Multiple Organ Failure
por: Humes, H. David, et al.
Publicado: (2023)

Failure of Recombinant Activated Factor VII in Treatment of Diffuse Alveolar Hemorrhage due to Cryoglobulinemic Vasculitis
por: Khoulani, Dania, et al.
Publicado: (2014)

Intravenous Iron Dextran as a Component of Anemia Management in Chronic Kidney Disease: A Report of Safety and Efficacy
por: Yessayan, Lenar, et al.
Publicado: (2013)

Iron repletion is associated with reduction in platelet counts in non-dialysis chronic kidney disease patients independent of erythropoiesis-stimulating agent use: a retrospective cohort study
por: Yessayan, Lenar, et al.
Publicado: (2014)

Silent disease progression in clinically stable heart failure
por: Sabbah, Hani N.
Publicado: (2016)

Surviving the Pandemic With Heart Failure
por: Buffington, Robert
Publicado: (2021)

Diagnostic value of end tidal capnography in patients with hyperglycemia in the emergency department
por: Bou Chebl, Ralphe, et al.
Publicado: (2016)

Experience With Pediatric Medical Device Development
por: Humes, H. David, et al.
Publicado: (2020)

A Biomimetic Membrane Device That Modulates the Excessive Inflammatory Response to Sepsis
por: Ding, Feng, et al.
Publicado: (2011)

Imipenem/Relebactam Ex Vivo Clearance during Continuous Renal Replacement Therapy
por: Jang, Soo Min, et al.
Publicado: (2021)

Effect of hyperchloremia on acute kidney injury in critically ill septic patients: a retrospective cohort study
por: Yessayan, Lenar, et al.
Publicado: (2017)

Right ventricular failure following left ventricular assist device implantation is associated with a preoperative pro-inflammatory response
por: Tang, Paul C., et al.
Publicado: (2019)

Impact of Acute Kidney Injury and CKD on Adverse Outcomes in Critically Ill Septic Patients
por: Neyra, Javier A., et al.
Publicado: (2018)

Effects of elamipretide on skeletal muscle in dogs with experimentally induced heart failure
por: Sabbah, Hani N., et al.
Publicado: (2019)

“Digital biomarkers” in preclinical heart failure models — a further step towards improved translational research
por: Schmidt, Alexander, et al.
Publicado: (2022)

Calpain Inhibition Reduces Amplitude and Accelerates Decay of the Late Sodium Current in Ventricular Myocytes from Dogs with Chronic Heart Failure
por: Undrovinas, Albertas, et al.
Publicado: (2013)

Immunomodulatory Treatment Strategies Targeting B Cells for Heart Failure
por: Zhang, Xinxin, et al.
Publicado: (2022)

Current Status of Immunomodulatory and Cellular Therapies in Preclinical and Clinical Islet Transplantation
por: Chhabra, Preeti, et al.
Publicado: (2011)

Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders
por: Kiss, Béla, et al.
Publicado: (2021)

Survival rate in acute kidney injury superimposed COVID-19 patients: a systematic review and meta-analysis
por: Ali, Hatem, et al.
Publicado: (2020)

Honey Bee Products: Preclinical and Clinical Studies of Their Anti-inflammatory and Immunomodulatory Properties
por: El-Seedi, Hesham R., et al.
Publicado: (2022)

The discovery of rivaroxaban: translating preclinical assessments into clinical practice
por: Kubitza, Dagmar, et al.
Publicado: (2013)

Immunomodulatory Device Therapy in a Pediatric Patient With Acute Kidney Injury and Multiorgan Dysfunction
por: Selewski, David T., et al.
Publicado: (2017)

A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury
por: Tumlin, James A., et al.
Publicado: (2015)

Cardiac Xenotransplantation: Progress in Preclinical Models and Prospects for Clinical Translation
por: Singh, Avneesh K., et al.
Publicado: (2022)

Determining optimal donor heart ischemic times in adult cardiac transplantation
por: Tang, Paul C., et al.
Publicado: (2022)

Improving Translational Relevance in Preclinical Psychopharmacology (iTRIPP)
por: Bailey, Sarah J, et al.
Publicado: (2023)

Incidence of Preclinical Heart Failure in a Community Population
por: Young, Kathleen A., et al.
Publicado: (2022)

Anti-LINGO-1 has no detectable immunomodulatory effects in preclinical and phase 1 studies
por: Ranger, Ann, et al.
Publicado: (2017)

The role of B cells in heart failure and implications for future immunomodulatory treatment strategies
por: García‐Rivas, Gerardo, et al.
Publicado: (2020)

Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation
por: Rosca, Mariana G., et al.
Publicado: (2008)

Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond
por: Teerlink, John R., et al.
Publicado: (2009)

Predicting need for heart failure advanced therapies using an interpretable tropical geometry-based fuzzy neural network
por: Zhang, Yufeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t6h6ta60jt14e59ev7o0irc1hd